Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiu-Ying Qin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
4-Amino-3,5-dichloro-benzene-sulfonamideXiu-Ying Qin, Han-Fu Liu, Jia-Xun Lin
Dalton Transactions (Cambridge, England : 2003)|April 23, 2020
Two novel chiral tetranucleate copper-based complexes: crystal structures, nanoparticles, and inhibiting angiogenesis and the growth of human breast cancer by regulating the VEGF/VEGFR2 signal pathway in vitroPei-Lu Zhang, Xiao-Xiao Hou, Mei-Rong Liu, et al.
Dalton Transactions (Cambridge, England : 2003)|August 4, 2023
A novel chiral oxazoline copper(II)-based complex inhibits ovarian cancer growth <i>in vitro</i> and <i>in vivo</i> by regulating VEGF/VEGFR2 downstream signaling pathways and apoptosis factorsRong Fan, Jing-Chen Wei, Bing-Bing Xu, et al.
Apoptosis : an International Journal on Programmed Cell Death|July 27, 2025
Novel L-type chiral metal(II) complexes inhibit breast cancer growth through synergistic effects of anti-angiogenesis, anti-inflammatory, apoptosis induction and cuproptosisNan Jin, Bing-Bing Xu, Hong-Yu Lin, et al.
Journal of Medicinal Chemistry|April 18, 2024
Arene-Arene Coupled Disulfamethazines (or Sulfadiazine)-Phenanthroline-Metal(II) Complexes were Synthesized by In Situ Reactions and Inhibited the Growth and Development of Triple-Negative Breast Cancer through the Synergistic Effect of Antiangiogenesis, Anti-Inflammation, Pro-Apoptosis, and CuproptosisBing-Bing Xu, Nan Jin, Ji-Cheng Liu, et al.
Dalton Transactions (Cambridge, England : 2003)|November 17, 2017
Synthesis, characterization, and anticancer activity of two mixed ligand copper(ii) complexes by regulating the VEGF/VEGFR2 signaling pathwayXiu-Ying Qin, Ya-Nan Wang, Xin-Ping Yang, et al.
European Journal of Medicinal Chemistry|October 15, 2024
Syntheses, crystal structures of copper (II)-based complexes of sulfonamide derivatives and their anticancer effects through the synergistic effect of anti-angiogenesis, anti-inflammation, pro-apoptosis and cuproptosisAi-Qiu Liao, Juan Wen, Jing-Chen Wei, et al.
Chemmedchem|May 21, 2014
Mixed-ligand mononuclear copper(II) complex: crystal structure and anticancer activityXiu-Ying Qin, Ya-Nan Liu, Qian-Qian Yu, et al.
Dalton Transactions (Cambridge, England : 2003)|September 13, 2013
Structures and anti-cancer properties of two binuclear copper complexesXiu Ying Qin, Li Cong Yang, Fang Ling Le, et al.
Metallomics : Integrated Biometal Science|November 22, 2019
Anti-cancer activities of metal-based complexes by regulating the VEGF/VEGFR2 signaling pathway and apoptosis-related factors Bcl-2, Bax, and caspase-9 to inhibit angiogenesis and induce apoptosisXiu-Ying Qin, Ya-Nan Wang, Han-Fu Liu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
4-Amino-3,5-dichloro-benzene-sulfonamideXiu-Ying Qin, Han-Fu Liu, Jia-Xun Lin
Dalton Transactions (Cambridge, England : 2003)|April 23, 2020
Two novel chiral tetranucleate copper-based complexes: crystal structures, nanoparticles, and inhibiting angiogenesis and the growth of human breast cancer by regulating the VEGF/VEGFR2 signal pathway in vitroPei-Lu Zhang, Xiao-Xiao Hou, Mei-Rong Liu, et al.
Dalton Transactions (Cambridge, England : 2003)|August 4, 2023
A novel chiral oxazoline copper(II)-based complex inhibits ovarian cancer growth <i>in vitro</i> and <i>in vivo</i> by regulating VEGF/VEGFR2 downstream signaling pathways and apoptosis factorsRong Fan, Jing-Chen Wei, Bing-Bing Xu, et al.
Apoptosis : an International Journal on Programmed Cell Death|July 27, 2025
Novel L-type chiral metal(II) complexes inhibit breast cancer growth through synergistic effects of anti-angiogenesis, anti-inflammatory, apoptosis induction and cuproptosisNan Jin, Bing-Bing Xu, Hong-Yu Lin, et al.
Journal of Medicinal Chemistry|April 18, 2024
Arene-Arene Coupled Disulfamethazines (or Sulfadiazine)-Phenanthroline-Metal(II) Complexes were Synthesized by In Situ Reactions and Inhibited the Growth and Development of Triple-Negative Breast Cancer through the Synergistic Effect of Antiangiogenesis, Anti-Inflammation, Pro-Apoptosis, and CuproptosisBing-Bing Xu, Nan Jin, Ji-Cheng Liu, et al.
Dalton Transactions (Cambridge, England : 2003)|November 17, 2017
Synthesis, characterization, and anticancer activity of two mixed ligand copper(ii) complexes by regulating the VEGF/VEGFR2 signaling pathwayXiu-Ying Qin, Ya-Nan Wang, Xin-Ping Yang, et al.
European Journal of Medicinal Chemistry|October 15, 2024
Syntheses, crystal structures of copper (II)-based complexes of sulfonamide derivatives and their anticancer effects through the synergistic effect of anti-angiogenesis, anti-inflammation, pro-apoptosis and cuproptosisAi-Qiu Liao, Juan Wen, Jing-Chen Wei, et al.
Chemmedchem|May 21, 2014
Mixed-ligand mononuclear copper(II) complex: crystal structure and anticancer activityXiu-Ying Qin, Ya-Nan Liu, Qian-Qian Yu, et al.
Dalton Transactions (Cambridge, England : 2003)|September 13, 2013
Structures and anti-cancer properties of two binuclear copper complexesXiu Ying Qin, Li Cong Yang, Fang Ling Le, et al.
Metallomics : Integrated Biometal Science|November 22, 2019
Anti-cancer activities of metal-based complexes by regulating the VEGF/VEGFR2 signaling pathway and apoptosis-related factors Bcl-2, Bax, and caspase-9 to inhibit angiogenesis and induce apoptosisXiu-Ying Qin, Ya-Nan Wang, Han-Fu Liu, et al.
Pageof 2